Literature DB >> 1752608

Heterogeneity of serum and amniotic fluid prolactin in humans.

H Fukuoka1, R Hamamoto, M Higurashi.   

Abstract

The molecular heterogeneity of PRL was studied in serum and amniotic fluid using immunoperoxidase electrophoresis. In the amniotic fluid, larger molecular variants (greater than 117 kD), small PRL (20 and 23 kD) and cleaved PRL were present in the nonreduced condition. Newly, three mercaptoethanol (MCE)-resistant forms (76, 64 and 53 kD), and 25- and 23-kD forms appeared after treatment with MCE. Two variants, 64 and 23 kD, did not bind to concanavalin A (Con A), indicating a simple peptide without sugars. Other glycosylated forms, 76, 53 and 25 kD, bound to Con A. In maternal serum, the same components as those in the amniotic fluid were seen, except for a scanty amount of 23 kD and a newly appearing glycosylated variant of 28 kD in the reduced condition. This 23-kD form also appeared with the administration of TRH in women.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752608     DOI: 10.1159/000181931

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  4 in total

1.  Heterogeneity in buffalo pituitary prolactin.

Authors:  S Khurana; K Muralidhar
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

3.  The effect of protein synthesis inhibitors on the glycosylation site occupancy of recombinant human prolactin.

Authors:  M Shelikoff; A J Sinskey; G Stephanopoulos
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 4.  Principles of the prolactin/vasoinhibin axis.

Authors:  Jakob Triebel; Thomas Bertsch; Cornelius Bollheimer; Daniel Rios-Barrera; Christy F Pearce; Michael Hüfner; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-26       Impact factor: 3.619

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.